Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122991616 | 12299161 | 6 | F | 20160816 | 20160425 | 20160817 | EXP | CA-ROCHE-1726531 | ROCHE | 0.00 | M | Y | 65.83000 | KG | 20160817 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122991616 | 12299161 | 1 | PS | ESBRIET | PIRFENIDONE | 1 | Oral | Y | 22535 | 267 | MG | TID | |||||||
| 122991616 | 12299161 | 2 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | Y | 22535 | 534 | MG | TID | |||||||
| 122991616 | 12299161 | 3 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | Y | 22535 | 267 | MG | TID | |||||||
| 122991616 | 12299161 | 4 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | Y | 22535 | 534 | MG | TID | |||||||
| 122991616 | 12299161 | 5 | SS | ESBRIET | PIRFENIDONE | 1 | Oral | Y | 22535 | 534 | MG | TID | |||||||
| 122991616 | 12299161 | 6 | SS | BIAXIN | CLARITHROMYCIN | 1 | Unknown | U | 0 | ||||||||||
| 122991616 | 12299161 | 7 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | 0 | ||||||||||||
| 122991616 | 12299161 | 8 | C | BRICANYL | TERBUTALINE SULFATE | 1 | 0 | ||||||||||||
| 122991616 | 12299161 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 122991616 | 12299161 | 10 | C | XARELTO | RIVAROXABAN | 1 | 0 | ||||||||||||
| 122991616 | 12299161 | 11 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122991616 | 12299161 | 1 | Idiopathic pulmonary fibrosis |
| 122991616 | 12299161 | 6 | Nasopharyngitis |
| 122991616 | 12299161 | 10 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122991616 | 12299161 | OT |
| 122991616 | 12299161 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122991616 | 12299161 | Asthenia | |
| 122991616 | 12299161 | Blood glucose increased | |
| 122991616 | 12299161 | Decreased appetite | |
| 122991616 | 12299161 | Diarrhoea | |
| 122991616 | 12299161 | Dysgeusia | |
| 122991616 | 12299161 | Haematochezia | |
| 122991616 | 12299161 | Nasopharyngitis | |
| 122991616 | 12299161 | Rectal haemorrhage | |
| 122991616 | 12299161 | Ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122991616 | 12299161 | 1 | 20160307 | 0 | ||
| 122991616 | 12299161 | 2 | 20160314 | 0 | ||
| 122991616 | 12299161 | 3 | 20160512 | 0 | ||
| 122991616 | 12299161 | 4 | 20160519 | 0 |